Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease.
Frangolias DD, Ruan J, Wilcox PJ, Davidson AG, Wong LT, Berthiaume Y, Hennessey R, Freitag A, Pedder L, Corey M, Sweezey N, Zielenski J, Tullis E, Sandford AJ. Frangolias DD, et al. Among authors: zielenski j. Am J Respir Cell Mol Biol. 2003 Sep;29(3 Pt 1):390-6. doi: 10.1165/rcmb.2002-0271OC. Epub 2003 Apr 14. Am J Respir Cell Mol Biol. 2003. PMID: 12689922
Glucose intolerance in children with cystic fibrosis.
Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, Pencharz P, Durie P, Sweezey NB. Solomon MP, et al. Among authors: zielenski j. J Pediatr. 2003 Feb;142(2):128-32. doi: 10.1067/mpd.2003.5. J Pediatr. 2003. PMID: 12584532
Genetic modifiers of lung disease in cystic fibrosis.
Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR; Gene Modifier Study Group. Drumm ML, et al. Among authors: zielenski j. N Engl J Med. 2005 Oct 6;353(14):1443-53. doi: 10.1056/NEJMoa051469. N Engl J Med. 2005. PMID: 16207846 Free article.
Complex two-gene modulation of lung disease severity in children with cystic fibrosis.
Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y, Sang R, Pereira L, Sun L, Berthiaume Y, Tsui LC, Paré PD, Durie P, Corey M, Zielenski J. Dorfman R, et al. Among authors: zielenski j. J Clin Invest. 2008 Mar;118(3):1040-9. doi: 10.1172/JCI33754. J Clin Invest. 2008. PMID: 18292811 Free PMC article.
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.
Ooi CY, Dorfman R, Cipolli M, Gonska T, Castellani C, Keenan K, Freedman SD, Zielenski J, Berthiaume Y, Corey M, Schibli S, Tullis E, Durie PR. Ooi CY, et al. Among authors: zielenski j. Gastroenterology. 2011 Jan;140(1):153-61. doi: 10.1053/j.gastro.2010.09.046. Epub 2010 Nov 9. Gastroenterology. 2011. PMID: 20923678
TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis.
Blohmke CJ, Park J, Hirschfeld AF, Victor RE, Schneiderman J, Stefanowicz D, Chilvers MA, Durie PR, Corey M, Zielenski J, Dorfman R, Sandford AJ, Daley D, Turvey SE. Blohmke CJ, et al. Among authors: zielenski j. J Immunol. 2010 Dec 15;185(12):7731-8. doi: 10.4049/jimmunol.1001513. Epub 2010 Nov 10. J Immunol. 2010. PMID: 21068401
A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies.
Taylor C, Commander CW, Collaco JM, Strug LJ, Li W, Wright FA, Webel AD, Pace RG, Stonebraker JR, Naughton K, Dorfman R, Sandford A, Blackman SM, Berthiaume Y, Paré P, Drumm ML, Zielenski J, Durie P, Cutting GR, Knowles MR, Corey M. Taylor C, et al. Among authors: zielenski j. Pediatr Pulmonol. 2011 Sep;46(9):857-69. doi: 10.1002/ppul.21456. Epub 2011 Apr 1. Pediatr Pulmonol. 2011. PMID: 21462361 Free PMC article.
96 results